Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

2009506 citationsJournal Article

Authors

Antje Moeller · Institute for Respiratory Health

Sarah E. Gilpin · Forma Therapeutics (United States)

Kjetil Ask · Forma Therapeutics (United States)

Gerard Cox · Institute for Respiratory Health

Deborah Cook · Institute for Respiratory Health

Jack Gauldie · Forma Therapeutics (United States)

Peter J. Margetts

Abstract

Fibrocytes are an indicator for disease activity of IPF and might be useful as a clinical marker for disease progression. This study suggests that quantification of circulating fibrocytes may allow prediction of early mortality in patients with IPF.

Topics & Keywords

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Medical Imaging and Pathology Studies Pleural and Pulmonary Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Respiratory and Critical Care Medicine

Volume 179, Issue 7, pp. 588-594

DOI: 10.1164/rccm.200810-1534oc

Field-Weighted Citation Impact: 38.23